Thermo Fisher Expands Clinical and Commercial Capabilities for Plasmid DNA Manufacturing December 16, 2020December 18, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailNew Carlsbad, California cGMP site will accelerate commercialization of plasmid-based medicines and vaccines Related News: Opening Ceremony Held for New Building at The…Telix Partnership Expands GE Healthcare…Rakuten Medical and Shimadzu Enroll First Patient in…QIAGEN launches new solutions that significantly…World's First Automated Solution For Extraction of…Super-resolution Live Cell Imaging to Study DNA…
